(Q38066148)

28 August 2017

1 reference

title

Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective (English)

1 reference

28 August 2017

0 references

1 reference

Jardin Leleux

1

1 reference

28 August 2017

Krishnendu Roy

series ordinal

2

1 reference

28 August 2017

publication date

6 December 2012

1 reference

Advanced Healthcare Materials

28 August 2017

published in

1 reference

28 August 2017

volume

2

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

72-94

1 reference

Immunomodulatory agents for prophylaxis and therapy of infections

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Vaccines: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Rationalizing the development of live attenuated virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

21 January 2018

Vaccines and vaccination

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The development of vaccines: how the past led to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Principles of vaccine design-Lessons from nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Innate immunity and adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Antigen-presenting cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Innate immunity: impact on the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Decisions about dendritic cells: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Origin, maturation and antigen presenting function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

T-Cell Function and Migration — Two Sides of the Same Coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

CD4 T cells: fates, functions, and faults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The long-term survival of plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Correlates of protection induced by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Contributions of humoral and cellular immunity to vaccine-induced protection in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Emerging concepts on the role of innate immunity in the prevention and control of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Recent developments in adjuvants for vaccines against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The perfect mix: recent progress in adjuvant research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Biomaterials as vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Vaccine adjuvants: scientific challenges and strategic initiatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Advances in vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Progress in understanding adjuvant immunotoxicity mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Signaling in innate immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Toll-like receptors and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Role of TLR- / NLR-signaling and the associated cytokines involved in recruitment of neutrophils in murine models of Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

MyD88, an adapter protein involved in interleukin-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Toll-like receptors; their physiological role and signal transduction system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Signaling to NF-kappaB by Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

21 January 2018

TLR based therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

NLRs join TLRs as innate sensors of pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Myeloid C-type lectin receptors in pathogen recognition and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Microparticles as vaccine adjuvants and delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Particulate vaccines: on the quest for optimal delivery and immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Microparticles as potentially orally active immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The cell biology of cross-presentation and the role of dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Design of biodegradable particles for protein delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Cationic PLA nanoparticles for DNA delivery: comparison of three surface polycations for DNA binding, protection and transfection properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Particle size determines activation of the innate immune system in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Pathogen recognition and development of particulate vaccines: does size matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Gastrointestinal uptake of biodegradable microparticles: effect of particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Nanotechnology solutions for mucosal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Immunomodulatory biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Streptococcus equi antigens adsorbed onto surface modified poly-epsilon-caprolactone microspheres induce humoral and cellular specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Synthesis and characterization of PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Release profile characteristics of biodegradable-polymer-coated drug particles fabricated by dual-capillary electrospray

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Programming the magnitude and persistence of antibody responses with innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Encapsulation of nucleic acids and opportunities for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Synthesis of protein-loaded hydrogel particles in an aqueous two-phase system for coincident antigen and CpG oligonucleotide delivery to antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

A Protective Vaccine Delivery System for In Vivo T Cell Stimulation Using Nanoengineered Polymer Hydrogel Capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core-shell gel particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Natural polymers for gene delivery and tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Protein release from alginate matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Alginate hydrogels as synthetic extracellular matrix materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Effect of alginate on innate immune activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Chitosan and its derivatives in mucosal drug and vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Chitosan-based systems for the delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Toll-like receptor-7 agonist decoration enhances the adjuvanticity of chitosan-DNA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Encapsulation performance of layer-by-layer microcapsules for proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Surface-engineered polyelectrolyte multilayer capsules: synthetic vaccines mimicking microbial structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Lyophilization of protein-loaded polyelectrolyte microcapsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Induction of high antitoxin titers against tetanus toxoid in rabbits by intranasal immunization with dextran microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Formulation and testing of vancomycin loaded albumin microspheres prepared by spray-drying.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Alginate-chitosan-PLGA composite microspheres enabling single-shot hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Disease-responsive drug delivery: the next generation of smart delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In vivo studies on the effect of co-encapsulation of CpG DNA and antigen in acid-degradable microparticle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

pH-triggered microparticles for peptide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Hydrodynamic structure of bovine serum albumin determined by transient electric birefringence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Encapsulation of water-insoluble drug by a cross-linking technique: effect of process and formulation variables on encapsulation efficiency, particle size, and in vitro dissolution rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Physical methods of nucleic acid transfer: general concepts and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Complexity of dendritic cell subsets and their function in the host immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Immunoglobulin class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The immunoglobulin class switch: beyond "accessibility".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The habitat, double life, citizenship, and forgetfulness of IgA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Regulation of mast-cell and basophil function and survival by IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

DNA immunization via intramuscular and intradermal routes using a gene gun provides different magnitudes and durations on immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Antigen processing and presentation by a murine myoblast cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Particle-based vaccines for transcutaneous vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Female genital tract immunity: distinct immunological challenges for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Aerosol drug delivery: developments in device design and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

21 January 2018

Nasal vaccine innovation

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Application of chitosan microspheres for nasal delivery of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

New insights in mucosal vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Chitosan for mucosal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Chitosan microparticles as oral delivery system for tetanus toxoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

The vagina as a route for systemic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Role of particle size in phagocytosis of polymeric microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Materials engineering for immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

An injectable synthetic immune-priming center mediates efficient T-cell class switching and T-helper 1 response against B cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201200268

21 January 2018

Identifiers

DOI

10.1002/ADHM.201200268

1 reference

28 August 2017

1 reference